Michael W. Rowe

453 total citations
12 papers, 359 citations indexed

About

Michael W. Rowe is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Epidemiology. According to data from OpenAlex, Michael W. Rowe has authored 12 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Michael W. Rowe's work include Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Cardiovascular Function and Risk Factors (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Michael W. Rowe is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Cardiovascular Function and Risk Factors (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (2 papers). Michael W. Rowe collaborates with scholars based in Denmark, United States and Australia. Michael W. Rowe's co-authors include Janice A. Kolberg, Torben Hansen, Oluf Pedersen, Torben Jørgensen, Knut Borch‐Johnsen, Robert Gerwien, Edward J. Moler, Mickey S. Urdea, Sarah Hamren and Michael P. McKenna and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Michael W. Rowe

12 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael W. Rowe Denmark	7	178	111	75	75	53	12	359
José S. Subauste United States	13	217 1.2×	130 1.2×	53 0.7×	54 0.7×	26 0.5×	35	399
Nozomi Tochiki Japan	12	144 0.8×	55 0.5×	96 1.3×	132 1.8×	42 0.8×	20	404
Huo Wu China	12	233 1.3×	105 0.9×	82 1.1×	28 0.4×	17 0.3×	16	439
Mina Hamano Japan	10	130 0.7×	54 0.5×	34 0.5×	184 2.5×	37 0.7×	14	382
Mika Shimamura Japan	12	216 1.2×	157 1.4×	142 1.9×	48 0.6×	21 0.4×	27	410
Antoinette Bugyei‐Twum Canada	9	195 1.1×	57 0.5×	52 0.7×	53 0.7×	36 0.7×	11	416
Norihiro Chatani Japan	9	134 0.8×	49 0.4×	33 0.4×	184 2.5×	32 0.6×	10	355
Marco Y. W. Zaki United Kingdom	9	104 0.6×	49 0.4×	40 0.5×	184 2.5×	36 0.7×	17	364
Sumihiko Hagita Japan	8	147 0.8×	58 0.5×	23 0.3×	72 1.0×	43 0.8×	12	404
Stephen A. Hoang United States	11	265 1.5×	63 0.6×	104 1.4×	215 2.9×	51 1.0×	16	573

Countries citing papers authored by Michael W. Rowe

Since Specialization

Citations

This map shows the geographic impact of Michael W. Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Rowe more than expected).

Fields of papers citing papers by Michael W. Rowe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Rowe. The network helps show where Michael W. Rowe may publish in the future.

Co-authorship network of co-authors of Michael W. Rowe

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Rowe. A scholar is included among the top collaborators of Michael W. Rowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Rowe. Michael W. Rowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Ahluwalia, Tarunveer S., Kristine H. Allin, Camilla H. Sandholt, et al.. (2015). Discovery of Coding Genetic Variants Influencing Diabetes-Related Serum Biomarkers and Their Impact on Risk of Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 100(4). E664–E671. 20 indexed citations

Tarasow, Theodore M., Michael W. Rowe, Mojgan Haddad, & Kathryn Sykes. (2015). Abstract 2010: Immunosignature technology detects stage I lung cancer from a drop of serum. Cancer Research. 75(15_Supplement). 2010–2010. 2 indexed citations

Wilsgaard, Tom, Ellisiv B. Mathiesen, Anil Patwardhan, et al.. (2015). Clinically Significant Novel Biomarkers for Prediction of First Ever Myocardial Infarction. Circulation Cardiovascular Genetics. 8(2). 363–371. 22 indexed citations

Watkins, Steven M., Michael W. Rowe, Janice A. Kolberg, Lynne E. Wagenknecht, & Richard N. Bergman. (2012). Biomarker models as surrogates for the disposition index in the Insulin Resistance Atherosclerosis Study. Diabetic Medicine. 29(11). 1399–1406. 3 indexed citations

Rowe, Michael W., Richard N. Bergman, Lynne E. Wagenknecht, & Janice A. Kolberg. (2012). Performance of a multi‐marker Diabetes Risk Score in the Insulin Resistance Atherosclerosis Study (IRAS), a multi‐ethnic US cohort. Diabetes/Metabolism Research and Reviews. 28(6). 519–526. 11 indexed citations

Jørgensen, Torben, Robert Gerwien, Torben Hansen, et al.. (2011). Validation of a multi-marker model for the prediction of incident type 2 diabetes mellitus: Combined results of the Inter99 and Botnia studies. Diabetes and Vascular Disease Research. 9(1). 59–67. 18 indexed citations

Gerwien, Robert, Michael W. Rowe, Edward J. Moler, et al.. (2010). Development of a Type 2 Diabetes Risk Model From a Panel of Serum Biomarkers From the Inter99 Cohort. Diabetes Care. 33(2). e29–e29. 4 indexed citations

McKenna, Michael P., Valeriya Lyssenko, Michael W. Rowe, et al.. (2009). The diabetes risk score outperforms fasting plasma glucose and glucose tolerance tests: combined results from the Inter99 and Botnia Studies. Lund University Publications (Lund University). 1 indexed citations

Urdea, Mickey S., Janice A. Kolberg, Judith C. Wilber, et al.. (2009). Validation of a Multimarker Model for Assessing Risk of Type 2 Diabetes from a Five-Year Prospective Study of 6784 Danish People (Inter99). Journal of Diabetes Science and Technology. 3(4). 748–755. 33 indexed citations

10.

Kolberg, Janice A., Torben Jørgensen, Robert Gerwien, et al.. (2009). Development of a Type 2 Diabetes Risk Model From a Panel of Serum Biomarkers From the Inter99 Cohort. Diabetes Care. 32(7). 1207–1212. 130 indexed citations

11.

Fanton, Christie, Michael W. Rowe, Edward J. Moler, et al.. (2006). Development of a Screening Assay for Surrogate Markers of Chk1 Inhibitor-Induced Cell Cycle Release. SLAS DISCOVERY. 11(7). 792–806. 4 indexed citations

12.

Brooks, Eric E., Nathanael S. Gray, Alison Joly, et al.. (1997). CVT-313, a Specific and Potent Inhibitor of CDK2 That Prevents Neointimal Proliferation. Journal of Biological Chemistry. 272(46). 29207–29211. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact